Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 91 entries
View as:

Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.

Phase: N/A Priority: Normal
NCT ID: NCT03855826 Org: User:
Start: 01/15/19 End: 01/30/20 Due: 01/30/21

A Study of BL-M07D1 + Pertuzumab With or Without Taxane Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06891833 Org: User:
Start: 06/05/25 End: 12/31/28 Due: 12/31/29

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06500026 Org: User:
Start: 08/07/24 End: 07/31/26 Due: 07/31/27

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06304974 Org: User:
Start: 03/19/24 End: 05/31/26 Due: 05/31/27

A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06131450 Org: User:
Start: 02/29/24 End: 12/31/25 Due: 12/31/26

A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06838273 Org: User:
Start: 02/24/25 End: 12/31/28 Due: 12/31/29

A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06382129 Org: User:
Start: 05/17/24 End: 05/31/26 Due: 05/31/27

A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06382116 Org: User:
Start: 05/22/24 End: 05/31/26 Due: 05/31/27

A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05461768 Org: User:
Start: 08/09/22 End: 12/31/25 Due: 12/31/26

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05339685 Org: User:
Start: 05/20/22 End: 06/30/25 Due: 06/30/26

A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05943795 Org: User:
Start: 07/14/23 End: 07/31/26 Due: 07/31/27

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06857175 Org: User:
Start: 03/25/25 End: 12/31/27 Due: 12/31/28

A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06423885 Org: User:
Start: 10/31/24 End: 10/31/26 Due: 10/31/27

A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06954077 Org: User:
Start: 05/15/25 End: 12/31/27 Due: 12/31/28

A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06493864 Org: User:
Start: 08/26/24 End: 07/31/26 Due: 07/31/27

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06349811 Org: User:
Start: 04/19/24 End: 05/31/26 Due: 05/31/27

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06505824 Org: User:
Start: 08/02/24 End: 08/31/26 Due: 08/31/27

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT05104775 Org: User:
Start: 02/09/22 End: 12/31/25 Due: 12/31/26

Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05631964 Org: User:
Start: 01/05/23 End: 12/31/25 Due: 12/31/26

A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06857227 Org: User:
Start: 03/17/25 End: 12/31/27 Due: 12/31/28

A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05944978 Org: User:
Start: 08/16/23 End: 08/31/25 Due: 08/31/26

A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06500052 Org: User:
Start: 07/24/24 End: 08/31/26 Due: 08/31/27

A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06503783 Org: User:
Start: 08/24/24 End: 08/31/26 Due: 08/31/27

SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05020769 Org: User:
Start: 01/06/22 End: 06/30/25 Due: 06/30/26

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05039931 Org: User:
Start: 09/15/21 End: 06/30/23 Due: 06/30/24